Haloperidol action
Home A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Haloperidol action



Haldol Decanoate (Haloperidol Decanoate) Side Effects

9.23.2017 | John Addington
Haloperidol action
Haldol Decanoate (Haloperidol Decanoate) Side Effects

This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: a certain severe nervous system problem (severe CNS depression), Parkinson's disease.

Anorexia, constipation, diarrhea, hypersalivation, dyspepsia, nausea and vomiting.

Furthermore, it is recommended that patients being considered for haloperidol decanoate therapy have been treated with, and tolerate well, short-acting HALDOL (haloperidol) in order to reduce the possibility of an unexpected adverse sensitivity to haloperidol.

Haldol Decanoate (Haloperidol Decanoate) Side Effects

8.22.2017 | Ashley Kendal
Haloperidol action
Haldol Decanoate (Haloperidol Decanoate) Side Effects

The basic effects of haloperidol decanoate are no different from those of HALDOL with the exception of duration of action. Haloperidol blocks the effects of dopamine and increases its turnover rate; however, the precise mechanism of action is unknown.

Should it be necessary to reinstitute treatment, or increase the dosage of the agent, or switch to a different antipsychotic agent, this syndrome may be masked. It is suggested that all antipsychotic agents be discontinued if these symptoms appear. There is no known effective treatment for tardive dyskinesia; antiparkinson agents usually do not alleviate the symptoms of this syndrome.

A potentially fatal symptom complex sometimes referred to as Neuroleptic Malignant Syndrome (NMS) has been reported in association with antipsychotic drugs.

Haloperidol

7.21.2017 | Kaitlyn Leapman
Haloperidol action
Haloperidol

Antipsychotic action: Haloperidol is thought to exert antipsychotic effects by strong postsynaptic blockade of CNS dopamine receptors, thereby inhibiting.

haloperidol Apo-Haloperidol ◆, Haldol, Novo-Peridol ◆, Peridol ◆ haloperidol decanoate Haldol Decanoate 50, Haldol Decanoate 100, Haldol LA ◆ haloperidol lactate Haldol, Haldol Concentrate, Haloperidol Intensol.

Metabolism: Metabolized extensively by the liver; there may be only one active metabolite that’s less active than parent drug.

First-Generation Antipsychotics An Introduction

4.18.2017 | Natalie Carter
Haloperidol action
First-Generation Antipsychotics An Introduction

This article is an introduction to terminology, mechanism of action,. effect, but not that haloperidol is more effective than chlorpromazine.

Table 2: Non-phenothiazine antipsychotics.

In order to avoid confusion regarding effectiveness in schizophrenia, the World Psychiatric Association suggested the term first-generation antipsychotics.

Level/degree of effect: (+) – low (++) – moderate (+++) – high (++++) – very high.

As explained earlier, overactivity of this pathway is thought to be involved in the pathophysiology of positive symptoms of schizophrenia. Blockade of D2 receptors in the mesolimbic pathway has been proposed as a possible mechanism of antipsychotic action of first-generation agents.

Authors: Flavio Guzman, MD; Abimbola Farinde,PharmD Contents.

Table 1- Phenothiazines chemical classification.

Later it was discovered that these effects are not required for therapeutic actions.

Atypical antipsychotics mechanism of action

5.19.2017 | Nicholas Babcock
Haloperidol action
Atypical antipsychotics mechanism of action

RESULTS: Of the 31 antipsychotics examined, the older traditional antipsychotics such as trifluperazine, pimozide, chlorpromazine, fluphenazine, haloperidol.

This theory also explains why L-dopa psychosis responds to low atypical antipsychotic dosages, and it suggests various individualized treatment strategies. The "fast-off-D2" theory, on the other hand, predicts which antipsychotic compounds will or will not produce EPS and hyperprolactinemia and which compounds present a relatively low risk for tardive dyskinesia.

To understand how these drugs work, it is important to examine the atypical antipsychotics' mechanism of action and how it differs from that of the more typical drugs.